SERUM LEVELS OF INTERFERON-GAMMA, CYTOTOXIC FACTOR AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN CHILDHOOD HEMOPHAGOCYTIC SYNDROMES

被引:61
|
作者
IMASHUKU, S
IKUSHIMA, S
ESUMI, N
TODO, S
SAITO, M
机构
[1] Division of Pediatrics, Children's Research Hospital, and Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto
[2] Applied Research Laboratory of Chugai Pharmaceutical Co. Ltd., Tokyo
关键词
INTERFERON-GAMMA; CYTOTOXIC FACTOR; SOLUBLE INTERLEUKIN-2 RECEPTOR; MALIGNANT HISTIOCYTOSIS; VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME;
D O I
10.3109/10428199109107916
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Serum levels of interferon (IFN)-gamma, cytotoxic factor (CF) and soluble interleukin-2 receptor (sIL2R) were assayed in relation to hyperferritinemia in eleven cases of malignant histiocytosis (MH), seven of virus-associated hemophagocytic syndrome (VAHS) and one of familial erythrophagocytic lymphohistiocytosis (FEL). IFN-gamma was markedly elevated (>10,000 U/ml) in 5 MH cases and only in one case of VAHS. CF was significantly elevated (> 150 U/ml) in 5 MH and 4 VAHS/FEL patients. sIL2R were remarkably elevated (> 10,000 U/ml) in 5 MH and 4 VAHS patients. In individual cases, the patterns of these parameters were quite different, suggesting the existence of a variable pathophysiology in cases with hemophagocytic syndromes. In terms of the patients' outcome, high IFN-gamma or sIL2R levels were associated with a poor prognosis while high CF appeared to be associated with a better prognosis. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 50 条
  • [21] Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment
    V Arolt
    M Rothermundt
    K-P Wandinger
    H Kirchner
    Molecular Psychiatry, 2000, 5 : 150 - 158
  • [22] Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment
    Arolt, V
    Rothermundt, M
    Wandinger, KP
    Kirchner, H
    MOLECULAR PSYCHIATRY, 2000, 5 (02) : 150 - 158
  • [23] Interleukin-2 and interferon-gamma mRNA expression in canine anal furunculosis lesions and the effect of ciclosporin therapy
    Tivers, Michael S.
    Catchpole, Brian
    Gregory, Susan P.
    House, Arthur K.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 125 (1-2) : 31 - 36
  • [24] ENHANCED CELL-MEDIATED CYTOTOXICITY BY INTERFERON-GAMMA AND INTERLEUKIN-2 AGAINST SYNGENEIC MURINE MAMMARY ADENOCARCINOMA
    NAKAJIMA, I
    CHU, TM
    MOLECULAR BIOTHERAPY, 1992, 4 (01) : 47 - 52
  • [25] ENHANCED SERUM LEVELS OF SOLUBLE HLA CLASS-I MOLECULES ARE INDUCED BY TREATMENT WITH RECOMBINANT INTERFERON-GAMMA (IFN-GAMMA)
    AULITZKY, WE
    GROSSEWILDE, H
    WESTHOFF, U
    TILG, H
    AULITZKY, W
    GASTL, G
    HEROLD, M
    HUBER, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 86 (02) : 236 - 239
  • [26] NATURE AND POTENTIAL OF THE REACTIVE RESPONSE TO MOUSE MAMMARY ADENOCARCINOMA CELLS ENGINEERED WITH INTERLEUKIN-2, INTERLEUKIN-4 OR INTERFERON-GAMMA GENES
    MUSIANI, P
    MODESTI, A
    BRUNETTI, M
    MODICA, A
    VITULLO, P
    GULINO, A
    BOSCO, MC
    COLOMBO, MP
    NANNI, P
    CAVALLO, F
    PERICLE, F
    GIOVARELLI, M
    CAVALLO, R
    FORNI, G
    NATURAL IMMUNITY, 1994, 13 (2-3) : 93 - 101
  • [27] INDUCTION OF LYMPHOKINE-ACTIVATED KILLING WITH REDUCED SECRETION OF INTERLEUKIN-1-BETA, TUMOR-NECROSIS-FACTOR-ALPHA, AND INTERFERON-GAMMA BY INTERLEUKIN-2 ANALOGS
    HEATON, KM
    JU, G
    GRIMM, EA
    ANNALS OF SURGICAL ONCOLOGY, 1994, 1 (03) : 198 - 203
  • [28] Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immuuotherapy with doxorubicin, interleukin-2 and interferon-gamma
    Lumsden, AJ
    Codde, JP
    vanderMeide, PH
    Gray, BN
    ANTICANCER RESEARCH, 1996, 16 (3A) : 1145 - 1154
  • [29] IGRA-positive patients and interferon-gamma/interleukin-2 signatures: Can the Fluorospot assay provide further information?
    P. Bittel
    D. Mayor
    P. Iseli
    T. Bodmer
    F. Suter-Riniker
    Infection, 2014, 42 : 539 - 543
  • [30] Induction of major histocompatibility complex class II antigens on human colonic epithelium by interferon-gamma, tumor necrosis factor-alpha, and interleukin-2
    Horie, Y
    Chiba, M
    Suzuki, T
    Kudo, T
    Kamata, A
    Iizuka, M
    Masamune, O
    JOURNAL OF GASTROENTEROLOGY, 1998, 33 (01) : 39 - 47